ArticlePloS one2013

Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy.

Christoph Daniel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.